AC Immune ACIU
NASDAQ ACIU
$2.86 -0.07 (-2.39%)
At close: Sep 4, 2026 · 4:00 PM EDT

AC Immune (ACIU) Operating Margin Growth (3y) (2018 - 2025)

Analysis

AC Immune (ACIU) Operating Margin Growth (3y) (2018 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -377.00
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -204.00
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 7,045.00
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -1,934.00
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 7,261.00
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 9,003.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - -2,649.00
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 30,461.00
10 AC Immune 285.13 Mn 285.13 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 186.54 Mn
Sep 30, 2025 -137,940.00
Dec 31, 2022 -186.75 Mn
Sep 30, 2022 -39,603.00
Dec 31, 2020 -208,474.00
Sep 30, 2020 -77,695.00
Jun 30, 2020 -35,246.00
Mar 31, 2020 33,107.00
Dec 31, 2019 -129,844.00
Sep 30, 2019 65,966.00
Jun 30, 2019 -104,021.00
Mar 31, 2019 126,784.00
Dec 31, 2018 191,369.00
Sep 30, 2018 -60,732.00